Corrigendum to "Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer".
Publication
, Journal Article
Bari, S; Muzaffar, J; Chan, A; Jain, SR; Haider, AM; Adams Curry, M; Hostler, CJ
Published in: J Oncol
2019
[This corrects the article DOI: 10.1155/2019/2989048.].
Duke Scholars
Published In
J Oncol
DOI
ISSN
1687-8450
Publication Date
2019
Volume
2019
Start / End Page
7921582
Location
Egypt
Related Subject Headings
- 5203 Clinical and health psychology
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1108 Medical Microbiology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bari, S., Muzaffar, J., Chan, A., Jain, S. R., Haider, A. M., Adams Curry, M., & Hostler, C. J. (2019). Corrigendum to "Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer". J Oncol, 2019, 7921582. https://doi.org/10.1155/2019/7921582
Bari, Shahla, Jameel Muzaffar, Austin Chan, Sanjay R. Jain, Ahmad M. Haider, Marjorie Adams Curry, and Christopher J. Hostler. “Corrigendum to "Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer".” J Oncol 2019 (2019): 7921582. https://doi.org/10.1155/2019/7921582.
Bari S, Muzaffar J, Chan A, Jain SR, Haider AM, Adams Curry M, et al. Corrigendum to "Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer". J Oncol. 2019;2019:7921582.
Bari, Shahla, et al. “Corrigendum to "Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer".” J Oncol, vol. 2019, 2019, p. 7921582. Pubmed, doi:10.1155/2019/7921582.
Bari S, Muzaffar J, Chan A, Jain SR, Haider AM, Adams Curry M, Hostler CJ. Corrigendum to "Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer". J Oncol. 2019;2019:7921582.
Published In
J Oncol
DOI
ISSN
1687-8450
Publication Date
2019
Volume
2019
Start / End Page
7921582
Location
Egypt
Related Subject Headings
- 5203 Clinical and health psychology
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1108 Medical Microbiology
- 1103 Clinical Sciences